Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Biotech
Fierce Biotech's top 10 editor's picks for 2024
From the conference circuit to the Nasdaq trading floor, we run down some of the highlights from Fierce Biotech's coverage this year.
James Waldron
Dec 23, 2024 3:00am
Novo stock crashes after CagriSema misses weight-loss goal
Dec 20, 2024 8:15am
Novo taps Photys for multi-molecule cardiometabolic collab
Dec 18, 2024 7:30am
Evotec, Novo collab debuts first 3 projects, adds 5 partners
Dec 12, 2024 2:27pm
Novo Nordisk discards $1.3B kidney drug in wake of phase 3 fail
Nov 6, 2024 4:54am
In $285M deal, Novo taps Ascendis to help create monthly GLP-1
Nov 4, 2024 8:43am
